当前位置:科学网首页 > 小柯机器人 >详情
科学家揭示嘧啶从头生物合成复合物在癌细胞增殖和铁死亡过程中的功能
作者:小柯机器人 发布时间:2023/6/10 13:43:17

首都医科大学Binghui Li研究小组的最新研究表明,嘧啶从头生物合成复合物为癌细胞增殖和抵抗铁死亡提供支持。这一研究成果发表在2023年6月8日出版的国际学术期刊《自然—细胞生物学》杂志上。

研究人员表明胞质谷氨酸草酰乙酸转氨酶1与二氢乳清酸酶(CAD)和尿苷5′-单磷酸合酶(UMPS)形成复合物,然后该复合物与线粒体二氢乳清酸脱氢酶(DHODH)连接,DHODH由线粒体外膜蛋白电压依赖性阴离子选择性通道蛋白3介导。因此,这些蛋白质形成一种多酶复合物,称为“嘧啶小体”,AMP活化蛋白激酶(AMPK)作为调节因子。活化的AMPK从复合物中解离以增强嘧啶小体组装,但失活的UMPS会促进DHODH介导的铁死亡防御。同时,AMPK表达较低的癌细胞更依赖于嘧啶酶体介导的UMP生物合成,并且更容易受到其抑制。

该研究结果揭示了嘧啶酶体在调节嘧啶合成和铁死亡中的作用,并证明靶向嘧啶体是潜在的癌症治疗策略。

研究人员表示,嘧啶从头生物合成是由胞质氨基甲酰磷酸合成酶II、天冬氨酸甲酰转氨酶、CAD、UMPS以及DHODH催化产生的。 然而,尚不知道这些酶是如何协作完成这一反应的。

附:英文原文

Title: De novo pyrimidine biosynthetic complexes support cancer cell proliferation and ferroptosis defence

Author: Yang, Chuanzhen, Zhao, Yiliang, Wang, Liao, Guo, Zihao, Ma, Lingdi, Yang, Ronghui, Wu, Ying, Li, Xuexue, Niu, Jing, Chu, Qiaoyun, Fu, Yanxia, Li, Binghui

Issue&Volume: 2023-06-08

Abstract: De novo pyrimidine biosynthesis is achieved by cytosolic carbamoyl-phosphate synthetase II, aspartate transcarbamylase and dihydroorotase (CAD) and uridine 5′-monophosphate synthase (UMPS), and mitochondrial dihydroorotate dehydrogenase (DHODH). However, how these enzymes are orchestrated remains enigmatical. Here we show that cytosolic glutamate oxaloacetate transaminase 1 clusters with CAD and UMPS, and this complex then connects with DHODH, which is mediated by the mitochondrial outer membrane protein voltage-dependent anion-selective channel protein 3. Therefore, these proteins form a multi-enzyme complex, named ‘pyrimidinosome’, involving AMP-activated protein kinase (AMPK) as a regulator. Activated AMPK dissociates from the complex to enhance pyrimidinosome assembly but inactivated UMPS, which promotes DHODH-mediated ferroptosis defence. Meanwhile, cancer cells with lower expression of AMPK are more reliant on pyrimidinosome-mediated UMP biosynthesis and more vulnerable to its inhibition. Our findings reveal the role of pyrimidinosome in regulating pyrimidine flux and ferroptosis, and suggest a pharmaceutical strategy of targeting pyrimidinosome in cancer treatment.

DOI: 10.1038/s41556-023-01146-4

Source: https://www.nature.com/articles/s41556-023-01146-4

期刊信息

Nature Cell Biology:《自然—细胞生物学》,创刊于1999年。隶属于施普林格·自然出版集团,最新IF:28.213
官方网址:https://www.nature.com/ncb/
投稿链接:https://mts-ncb.nature.com/cgi-bin/main.plex